Juan Sanchez | Vice President, Corporate Communications and Investor Relations |
Sharon Mates | Chairman and Chief Executive Officer |
Mark Neumann | Executive Vice President and Chief Commercial Officer |
Suresh Durgam | Executive Vice President Chief Medical Officer |
Larry Hineline | Senior Vice President and Chief Financial Officer |
Andrew Tsai | Jefferies |
Jessica Fye | JPMorgan |
Mike DiFiore | Evercore |
Brian Abrahams | RBC Capital Markets |
Charles Duncan | Cantor Fitzgerald |
Marc Goodman | SVB |
Karin Jenkins | Goldman Sachs |
Jason Gerberry | Bank of America |
Ash Verma | UBS |
Sumant Kulkarni | Canaccord |
Good morning, ladies and gentlemen, and welcome to the Intra-Cellular Therapies' Second Quarter Earnings Call. At this time, all participants on a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, today's conference is being recorded. I would now like to turn the conference over to Dr.